Abstract
The report covers forecast and analysis for the injection pen market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the injection pen market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the injection pen market on a global level.
In order to give the users of this report a comprehensive view of the injection pen market, we have included competitive landscape and analysis of Porter’s Five Forces model in the market. The study encompasses a market attractiveness analysis, where type, therapy, end-user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new type launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.
The study provides a decisive view of the injection pen market by segmenting the market based on type, therapy, end user, and regions. All the segments have been analyzed based on present and future trends and the market are estimated from 2018 to 2024.
Based on the type, the injection pen market is segmented as disposable and reusable pens. Based on therapy, the injection pen market is segmented hormone therapy, osteoporosis, fertility, diabetes, and other therapies. Based on the end user, the injection pen market is segmented as home care and hospitals.
Increased prevalence of chronic disorders is one of the major driving factors of the injection pen market. Increased demand coupled with increasing trend of home healthcare is expected to drive the growth of the injection pen market. However, alternate drug delivery methods and poor reimbursement policies are the factors that influence the market growth during the forecast period.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries, including the U.S., Germany, France, the UK, China, Japan, India, and Brazil. This segment includes demand for injection pen market based on individual segment and treatment in all the regions and countries.
The report also includes detailed profiles of end players such as Sanofi, and Eli Lilly and Company. Other major players in the injection pen market include Merck & co., Inc., Becton, Dickinson and Company (BD), Biocorp Production SA, F.Hoffman-La Roche Ltd, AstraZeneca PLC, Novo Nordisk, Pfizer, Owen Mumford Ltd, Ypsomed Holding AG, Novartis, Wilhelm Haselmeier GmbH & Co. KG, and others.
This report segments the global injection pen market as follows:
Global Injection Pen Market: Type Segment Analysis
Disposable
Reusable Pens
Global Injection Pen Market: Therapy Segment Analysis
Growth Hormone Therapy
Osteoporosis
Fertility
Diabetes
Other Therapies
Global Injection Pen Market: End-User Segment Analysis
Hospitals
Home care
Global Injection Pen Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa